| __timestamp | Alpine Immune Sciences, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 19586000 |
| Thursday, January 1, 2015 | 16054000 | 29135000 |
| Friday, January 1, 2016 | 23316000 | 42791000 |
| Sunday, January 1, 2017 | 10626000 | 49577000 |
| Monday, January 1, 2018 | 28970000 | 89209000 |
| Tuesday, January 1, 2019 | 35847000 | 69099000 |
| Wednesday, January 1, 2020 | 27185000 | 75961000 |
| Friday, January 1, 2021 | 58742000 | 90467000 |
| Saturday, January 1, 2022 | 70243000 | 74552000 |
| Sunday, January 1, 2023 | 80904000 | 91593000 |
Unlocking the unknown
In the competitive landscape of biopharmaceuticals, innovation is the lifeblood of progress. Over the past decade, Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated a steadfast commitment to research and development (R&D). From 2014 to 2023, Alpine Immune Sciences increased its R&D spending by over 560%, reflecting a strategic focus on pioneering therapies. Meanwhile, Supernus Pharmaceuticals, with a more consistent investment trajectory, saw a 370% rise in R&D expenses, underscoring its dedication to enhancing its product pipeline. Notably, in 2023, Supernus Pharmaceuticals allocated 13% more to R&D than Alpine Immune Sciences, highlighting its robust financial commitment to innovation. This decade-long analysis reveals the dynamic strategies of these companies as they navigate the ever-evolving pharmaceutical industry, striving to bring groundbreaking treatments to market.
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.